Vaccine equity: there is no time to waste.
作者信息
Bansal Akhil
机构信息
Stanford University, Existential Risk Initiative, 450 Serra Mall, Stanford, CA, 94305, United States of America.
出版信息
Bull World Health Organ. 2022 Jan 1;100(1):2-2A. doi: 10.2471/BLT.21.287655.
Abstract
摘要
相似文献
1
Vaccine equity: there is no time to waste.疫苗公平：刻不容缓。
Bull World Health Organ. 2022 Jan 1;100(1):2-2A. doi: 10.2471/BLT.21.287655.
2
Vaccine equity: a stress test for planetary health.疫苗公平性：对全球健康的压力测试。
Lancet Planet Health. 2021 Nov;5(11):e758-e759. doi: 10.1016/S2542-5196(21)00291-6.
3
Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity.在3期试验结果出来之前批准疫苗：疫苗获取不平等的一个后果。
Lancet. 2022 Mar 26;399(10331):1223-1224. doi: 10.1016/S0140-6736(22)00164-7. Epub 2022 Mar 2.
4
Technologies to advance COVID-19 vaccine equity.推进 COVID-19 疫苗公平性的技术。
Nat Biotechnol. 2021 Dec;39(12):1477. doi: 10.1038/s41587-021-01167-0.
5
Learning from past mistakes? The COVID-19 vaccine and the inverse equity hypothesis.从过去的错误中吸取教训？新冠疫苗与反向公平假说。
Eur J Public Health. 2021 Feb 1;31(1):2. doi: 10.1093/eurpub/ckaa243.
6
Regional vaccine production is key to ensuring equity.区域疫苗生产是确保公平的关键。
BMJ. 2021 Sep 28;374:n2354. doi: 10.1136/bmj.n2354.
7
COVID-19 vaccine equity and booster doses.新冠疫苗公平性与加强针
Lancet Infect Dis. 2021 Sep;21(9):1193. doi: 10.1016/S1473-3099(21)00486-2. Epub 2021 Aug 13.
8
Global plan seeks to promote vaccine equity, spread risks.全球计划旨在促进疫苗公平分配，分散风险。
Science. 2020 Jul 31;369(6503):489-490. doi: 10.1126/science.369.6503.489.
9
Failure to achieve global vaccine equity will have dire consequences.无法实现全球疫苗公平分配将产生严重后果。
BMJ. 2021 Mar 19;372:n712. doi: 10.1136/bmj.n712.
10
Canada is no global health leader on COVID-19 vaccine equity.在新冠疫苗公平性方面，加拿大并非全球健康领域的领导者。
Lancet. 2021 May 15;397(10287):1803. doi: 10.1016/S0140-6736(21)00888-6.
引用本文的文献
1
Analysis of key factors and equity in influenza vaccination among Chinese adults-evidence from a large national cross-sectional survey.中国成年人流感疫苗接种的关键因素及公平性分析——来自一项全国性大型横断面调查的证据
Front Public Health. 2025 Jun 5;13:1601577. doi: 10.3389/fpubh.2025.1601577. eCollection 2025.
2
Cost-effectiveness of preventive COVID-19 interventions: a systematic review and network meta-analysis of comparative economic evaluation studies based on real-world data.2019冠状病毒病预防性干预措施的成本效益：基于真实世界数据的比较经济评估研究的系统评价与网络荟萃分析
J Glob Health. 2025 Feb 21;15:04017. doi: 10.7189/jogh.15.04017.
3
How enlightened self-interest guided global vaccine sharing benefits all: A modeling study.从自利到共益：基于模型的全球疫苗公平分配策略研究。
J Glob Health. 2023 Dec 20;13:06038. doi: 10.7189/jogh.13.06038.
4
Enhancing Reciprocity, Equity and Quality of Ethics Review for Multisite Research During Public Health Crises: The Experience of the COVID-19 Clinical Research Coalition Ethics Working Group.加强公共卫生危机期间多地点研究的伦理审查的互惠性、公平性和质量：COVID-19 临床研究联盟伦理工作组的经验。
J Law Med Ethics. 2023;51(2):258-270. doi: 10.1017/jme.2023.75. Epub 2023 Sep 1.
5
Ethical implications for children's exclusion in the initial COVID-19 vaccination in Ghana.加纳儿童在新冠疫苗接种初期被排除在外的伦理影响。
Glob Bioeth. 2023 Jan 23;34(1):1-11. doi: 10.1080/11287462.2023.2168170. eCollection 2023.
6
Time-Dependent Changes in Death Reports and the Sex Ratio in the Safety Surveillance of SARS-CoV-2 Vaccination in Japan, the United States, and European Countries.日本、美国和欧洲国家新冠病毒疫苗安全性监测中死亡报告及性别比的时间依赖性变化
Cureus. 2022 Mar 22;14(3):e23380. doi: 10.7759/cureus.23380. eCollection 2022 Mar.
7
Predictors of Intention to Vaccinate Against COVID-19 in a Peruvian Sample.秘鲁人群中 COVID-19 疫苗接种意愿的预测因素。
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221092254. doi: 10.1177/21501319221092254.
8
The brave new world of pandemic resilience.疫情韧性的全新世界。
J Eval Clin Pract. 2022 Jun;28(3):347-352. doi: 10.1111/jep.13667. Epub 2022 Feb 14.
本文引用的文献
1
Conquering COVID: How Global Vaccine Inequality Risks Prolonging the Pandemic.战胜新冠疫情：全球疫苗不平等如何延长疫情大流行风险
Open Forum Infect Dis. 2021 Sep 9;8(10):ofab443. doi: 10.1093/ofid/ofab443. eCollection 2021 Oct.
2
A patent waiver on COVID vaccines is right and fair.新冠疫苗专利豁免是正确且公平的。
Nature. 2021 May;593(7860):478. doi: 10.1038/d41586-021-01242-1.
3
Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants.加快疫苗接种对于减轻高传染性的新冠病毒变异毒株的影响至关重要。
EClinicalMedicine. 2021 May;35:100865. doi: 10.1016/j.eclinm.2021.100865. Epub 2021 Apr 25.
Zotero 插件